<DOC>
	<DOC>NCT00310453</DOC>
	<brief_summary>The purpose of this trial is to assess whether the ALK Grass tablet treatment is safe to use in children aged 5-12 years</brief_summary>
	<brief_title>Tolerability of ALK Grass Tablet in Children</brief_title>
	<detailed_description />
	<criteria>Grass pollen induced rhinoconjunctivitis Boys and girls, 512 years of age Positive skin prick test to grass pollen Severe asthma Previous treatment with immunotherapy</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>May 2006</verification_date>
</DOC>